FAYBL Launches Autonomous General AI Agent on Iress's Xplan
SYDNEY, May 28, 2025 /PRNewswire/ -- FAYBL, a leading innovator in AI-driven financial advisory solutions, proudly announces the launch of its Autonomous General Agent, and successful integration with the API of Iress's (ASX:IRE) Xplan platform....
SingWealth Holdings Expands into Hong Kong with New Insurance Brokerage Licence
With the launch of PFPFA HK Limited, SingWealth Holdings reinforces its commitment to regional growth and delivering seamless, high-quality financial solutions through its licensed operations in Singapore and Hong Kong SAR. SINGAPORE, May 28, 2025...
Tesco's Clubcard Challenges, Powered by Eagle Eye, Wins "Best Global Loyalty Launch or Initiative" at the 2025 International Loyalty Awards
LONDON, May 28, 2025 /PRNewswire/ -- Tesco's Clubcard Challenges, powered by Eagle Eye's Personalised Challenges solution, has been named the Best Global Loyalty Launch or Initiative at the 2025 International Loyalty Awards. The award celebrates...
NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities
- Establishing High-quality Pharmaceutical Logistics Service Systems - TOKYO, May 28, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution...
Hollywood-Bound: Local Family-Owned Wellness Brand Takes Centre Stage in Hollywood's Coveted Mother's Day Gift Bag
GOLD COAST, Australia, May 28, 2025 /PRNewswire/ -- Australian family-owned and operated, Biosota Organics has officially gone Hollywood. The brand's award-winning high MGO-rated Manuka honey was featured in the highly anticipated 2025 Hollywood...
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment of Vibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr....
Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of...
D-Link Unveils the New DBR Router & Access Point
Empowering Secure, Seamless Connectivity for Small Businesses TAIPEI, May 28, 2025 /PRNewswire/ -- D-Link Corporation (TWSE: 2332), a global leader in networking solutions, is pleased to announce the launch of its latest DBR Series, which includes...